81375-97-5

Basic information

• Product Name: 3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE
• Synonyms: 3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE
• CAS NO: 81375-97-5
• Molecular Formula: C₁₁H₁₁NO₃S₂
• Molecular Weight: 270.34788
• Mol File: 81375-97-5.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 429.8°C at 760 mmHg
• Flash Point: 213.7°C
• Appearance: /
• Density: 1.322g/cm³
• Vapor Pressure: 1.36E-07mmHg at 25°C
• Refractive Index: 1.631
• CAS DataBase Reference: 3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE(81375-97-5)
• EPA Substance Registry System: 3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE(81375-97-5)

Safety Data

• Hazardous Substances Data: 81375-97-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H11NO3S2/c1-16-11(17-2)7-10(13)8-3-5-9(6-4-8)12(14)15/h3-7H,1-2H3

Upstream product

• 75-15-0 carbon disulfide 
• 100-19-6 (4-nitrophenyl)ethanone 
• 74-88-4 methyl iodide 
• 41501-63-7 2,2-dichlorovinyl 4-nitrophenyl ketone 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 134304-73-7 (E)-1-(4-nitrophenyl)-2-(oxazolidin-2-ylidene)ethanone 
• 881889-88-9 3,3-bis(methylsulfanyl)-2-(4-nitrobenzoyl)acrylaldehyde 
• 139057-23-1 [(Z)-1-Methylsulfanyl-3-(4-nitro-phenyl)-3-oxo-propenylamino]-acetic acid 
• 124927-43-1 2-(4-nitrobenzoylmethylene)imidazolidine 
• 13700-88-4 (Nitro-4 phenyl)-5 dithiole-1,2 thione-3 
• 881889-93-6 2-[3,3-bis(methylsulfanyl)-2-(4-nitrobenzoyl)-2-propenylidene]malononitrile 

Relevant articles and documents

COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF

The present disclosure provides the compound having inhibitory property against TNIK having a specific chemical structure or its pharmaceutically acceptable salt. The present disclosure also provides a composition comprising the compound or its pharmaceutically acceptable salt. The present disclosure also provides a medical use of the compound, its salt or the composition comprising the compound or its pharmaceutically acceptable salt for treating or preventing cancer. The present disclosure also provides a method of treatment or prevention of cancer comprising administering the compound, its salt or the composition comprising the compound or its salt to a subject in need of such treatment or prevention.

Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives

A series of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives, prepared by two synthetic routes, were in vitro assayed against three Trypanosoma strains, Leishmania donovani, and Plasmodium falciparum K1. Seven out of 17 compounds showed m

Infrared Spectra and Theoretical Study of the Conformations of Substituted Benzoylketene-S,S-acetals

The C=O stretching frequencies of substituted benzoylketene-S,S-dimethylacetals (1a-1o) and benzoylketene-S,S-ethyleneacetals (2a-2m) were measured in CHCl3 and CCl4 and correlated with the Hammett substituent constants.The correlations were split into tw